CDNA vs NWSA · rev $249.6M vs rev $9.03B
CareDx Inc (CDNA) versus NWSA (NWSA) — a side-by-side from cached financials, not a winner call.
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
NWSA (NWSA) common stock.
Latest reported CDNA revenue for 2026-06-30 was $249.6M. Net income was $113.4M. CDNA currently screens at market cap $1.18B.
Latest reported NWSA revenue for 2026-06-30 was $9.03B. Net income was $573.0M. Revenue was up 328.1% from 2025-06-30 to 2026-06-30. NWSA currently screens at market cap $0.
CDNA currently screens at market cap $1.18B. NWSA currently screens at market cap $0.
Not investment advice. Open the CDNA and NWSA stock pages for the full models.
Not investment advice.